[{"address1": "7750 El Camino Real", "address2": "Suite 2A", "city": "Carlsbad", "state": "CA", "zip": "92009", "country": "United States", "phone": "858 704 4900", "website": "https://www.palisadebio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. J. D. Finley", "age": 66, "title": "CEO, CFO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 813000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell Lawrence Jones M.D., Ph.D.", "age": 47, "title": "COO & Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 581000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joerg  Heyer Ph.D.", "title": "Head of Translational Science & Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryker  Willie", "title": "Senior VP of Finance & Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6794, "open": 0.6903, "dayLow": 0.66, "dayHigh": 0.6903, "regularMarketPreviousClose": 0.6794, "regularMarketOpen": 0.6903, "regularMarketDayLow": 0.66, "regularMarketDayHigh": 0.6903, "payoutRatio": 0.0, "beta": 1.41, "forwardPE": -0.07410088, "volume": 79589, "regularMarketVolume": 79589, "averageVolume": 2172484, "averageVolume10days": 284280, "averageDailyVolume10Day": 284280, "bid": 0.6639, "ask": 0.6888, "bidSize": 2, "askSize": 2, "marketCap": 6297882, "fiftyTwoWeekLow": 0.6, "fiftyTwoWeekHigh": 4.32, "fiftyDayAverage": 0.822, "twoHundredDayAverage": 1.1198, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1073722, "profitMargins": 0.0, "floatShares": 8618237, "sharesOutstanding": 9119150, "sharesShort": 424351, "sharesShortPriorMonth": 813858, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.045500003, "heldPercentInsiders": 0.00241, "heldPercentInstitutions": 0.059180003, "shortRatio": 0.08, "shortPercentOfFloat": 0.0468, "impliedSharesOutstanding": 9319150, "bookValue": 0.545, "priceToBook": 1.24, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11845000, "trailingEps": -3.64, "forwardEps": -9.12, "lastSplitFactor": "1:15", "lastSplitDate": 1712534400, "enterpriseToEbitda": -0.089, "52WeekChange": -0.81621623, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 0.6758, "targetHighPrice": 14.0, "targetLowPrice": 2.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 5429000, "totalCashPerShare": 0.595, "ebitda": -12125000, "totalDebt": 338000, "quickRatio": 1.369, "currentRatio": 1.624, "debtToEquity": 12.901, "returnOnAssets": -0.77592003, "returnOnEquity": -1.8848, "freeCashflow": -6058500, "operatingCashflow": -9664000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PALI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Palisade Bio, Inc.", "longName": "Palisade Bio, Inc.", "corporateActions": [], "postMarketTime": 1756511906, "regularMarketTime": 1756497600, "exchange": "NCM", "messageBoardId": "finmb_244367385", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.52987945, "regularMarketPrice": 0.6758, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1175261400000, "postMarketChangePercent": -0.873043, "postMarketPrice": 0.6699, "postMarketChange": -0.00590003, "regularMarketChange": -0.0036000013, "regularMarketDayRange": "0.66 - 0.6903", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2172484, "fiftyTwoWeekLowChange": 0.0758, "fiftyTwoWeekLowChangePercent": 0.12633333, "fiftyTwoWeekRange": "0.6 - 4.32", "fiftyTwoWeekHighChange": -3.6442, "fiftyTwoWeekHighChangePercent": -0.8435648, "fiftyTwoWeekChangePercent": -81.62162, "dividendDate": 1563408000, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.64, "epsForward": -9.12, "epsCurrentYear": -1.72333, "priceEpsCurrentYear": -0.39214778, "fiftyDayAverageChange": -0.1462, "fiftyDayAverageChangePercent": -0.17785887, "twoHundredDayAverageChange": -0.44399995, "twoHundredDayAverageChangePercent": -0.39649934, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Seneca Biopharma, Inc.", "nameChangeDate": "2025-08-29", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Palisade Bio", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]